Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$18.85 - $27.5 $397,527 - $579,947
-21,089 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$17.37 - $26.27 $47,559 - $71,927
2,738 Added 14.92%
21,089 $496,000
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $45,422 - $109,823
4,265 Added 30.28%
18,351 $430,000
Q4 2018

Feb 13, 2019

BUY
$9.26 - $16.38 $130,436 - $230,728
14,086 New
14,086 $156,000
Q3 2018

Nov 13, 2018

SELL
$7.54 - $18.31 $96,052 - $233,251
-12,739 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$4.87 - $8.42 $62,038 - $107,262
12,739 New
12,739 $94,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.